XML 41 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Incentive Plan (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Disclosure of Share-based Compensation Arrangements
The Company recorded share-based compensation expense as follows for the years ended December 31, 2022, 2021 and 2020:

Year Ended
December 31,
2022
December 31,
2021
December 31,
2020
Salaries, wages and employee benefits - continuing operations$9,902 $9,108 $9,715 
Salaries, wages and employee benefits - discontinued operation— 16 85 
Total share-based compensation expense$9,902 $9,124 $9,800 
Schedule of Weighted Average Assumptions
The weighted average grant-date fair value of the stock option awards granted under the Plan and the weighted average assumptions under the Black-Scholes option-pricing model were as follows for the years ended December 31, 2022, 2021 and 2020.
December 31,
2022
December 31,
2021
December 31,
2020
Weighted average grant-date fair value$28.91 $18.36 $14.79 
Weighted average assumptions under Black-Scholes option model:
Expected dividend yield0.9 %1.1 %1.1 %
Expected stock price volatility28.7 %28.9 %24.1 %
Risk-free interest rate1.9 %0.6 %1.5 %
Expected life of awards (years)5.65.85.9
Schedule of Stock Option Activity
Stock option transactions during the year ended December 31, 2022 on a continuing operations basis were as follows:
Number of Shares Weighted Average Exercise Price
Outstanding as of January 1342 $58.44 
Granted64 106.13 
Exercised(3)60.42 
Forfeited or Canceled(27)63.46 
Outstanding as of December 31376 $66.13 
The following table sets forth the exercise price range, number of shares, weighted average exercise price and remaining contractual lives by groups of similar price on a continuing operations basis as of December 31, 2022:

Stock Options OutstandingStock Options Exercisable
Range of Exercise PricesNumber of SharesWeighted Average Remaining Contractual Life (in years)Weighted Average Exercise PriceExercisable as of December 31, 2022Weighted Average Exercise Price
$43.67 -$65.96 279 1.9$56.67 267 $56.25 
$75.05 -$106.29 97 5.793.51 13 75.05 
376 $66.13 280 $57.13 
Schedule of Restricted Share Activity
Restricted share transactions on a continuing operations basis for the year ended December 31, 2022 were as follows:
Number of Shares Weighted Average Grant Date Fair Value
Outstanding as of January 1191 $69.84 
Granted82 105.64 
Vested(92)67.41 
Forfeited(30)84.70 
Outstanding as of December 31151 $87.82 
Director restricted share transactions for the year ended December 31, 2022 were as follows:
Number of Shares Weighted Average Grant Date Fair Value
Outstanding as of January 115 $93.46 
Granted15 93.70 
Vested(15)93.46 
Forfeited— — 
Outstanding as of December 3115 $93.70 

Year Ended
December 31,
2022
December 31,
2021
December 31,
2020
Share-based compensation expense for restricted shares$1,387 $1,436 $1,026 
Excess tax benefit for the vesting of restricted shares$12 $342 $253 
Schedule of Nonvested Performance-based Units Activity The weighted average grant-date fair value of performance awards granted under the Plan and the weighted average assumptions under the Monte Carlo simulation model were as follows for the years ended December 31, 2022, 2021 and 2020:
Year Ended
December 31,
2022
December 31,
2021
December 31,
2020
Weighted average grant-date fair value$127.29 $87.33 $69.15 
Weighted average assumptions under the Monte Carlo simulation model:
Expected stock price volatility35.5 %34.5 %23.5 %
Weighted average risk-free interest rate1.6 %0.2 %1.4 %
Schedule of Performance Award Transactions
Performance award transactions for the year ended December 31, 2022 on a continuing operations basis were as follows assuming target levels of performance:
Number of Shares Weighted Average Grant Date Fair Value
Outstanding as of January 179 $75.61 
Granted14 127.29 
Earned(7)63.40 
Forfeited or unearned (16)74.79 
Outstanding as of December 3170 $87.74 
Schedule of Employee Stock Purchase Plan
Employee stock purchase plan activity and related information was as follows on a continuing operations basis:
Year Ended
December 31, 2022December 31, 2021December 31, 2020
Shares purchased by participants under the ESPP12 14 
Average purchase price$82.48 $75.71 $44.24 
Weighted average fair value of each purchase under the ESPP granted1
$9.17 $30.68 $20.99 
Share-based compensation expense for ESPP$87 $369 $292 
1 Equal to the discount from the market value of the common stock at the end of each six month purchase period

Employee stock purchase plan activity and related information was as follows on a discontinued operation basis:
Year Ended
December 31, 2022December 31, 2021December 31, 2020
Shares purchased by participants under the ESPP— — 
Average purchase price$— $— $44.35 
Weighted average fair value of each purchase under the ESPP granted1
$— $— $18.11 
Share-based compensation expense for ESPP$— $— $20 
1 Equal to the discount from the market value of the common stock at the end of each six month purchase period